BNOX (Bionomics Ltd.) Rasio Nilai Pasar marang Nilai Buku

Simbol resmi perusahaan bionomics.com.au (BNOX)

Bionomics Limited (BNOX) is scaling its portfolio of CNS and anxiety disorder therapies through international centers. Molecule development is accelerating via AI tracking and robotic laboratories. The current market capitalization relative to book value confirms this progress, where 0.26 forms the current metric indicator. However, geopolitical conflicts and sanctions are hindering drug exports and the execution of global clinical trials.

BNOX bionomics.com.au: Nilai Pasar marang Nilai Buku ing interval 04.07.2022 - 24.12.2024

Rincian metrik keuangan lan pasar Bionomics Limited (BNOX)

- rega lan prakiraan konsensus rega:
Kutipan saham bionomics.com.au|BNOX - Prakiraan gabungan firma investasi
- data kapitalisasi pasar:
Nilai pasar Bionomics Ltd|BNOX - Nilai Wutuh Bisnis
- data kapitalisasi buku:
Nilai Buku saben Saham Bionomics|BNOX - Nilai Akuntansi Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku bionomics.com.au|BNOX - Total Aset Perusahaan
- data utang lan likuiditas:
Utang marang Ekuitas Bionomics Limited|BNOX - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas bionomics.com.au|BNOX - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Bionomics Ltd
Analisis wiwitan perusahaan:Bionomics Ltd. - BNOX
Produk asli bionomics.com.au

This ratio compares the market value of a business with its net assets, identifying overvaluation or systemic capital depreciation. An investor assesses whether a low multiple indicates undervaluation or is a result of business degradation. Analyzing the current price-to-book ratio allows for the filtering of value traps. For Bionomics Limited (BNOX), this metric reflects market confidence in intellectual capital. The prospects for the BNC210 drug and potential licensing agreements drive the dynamics of this indicator.

Pesaing utama

Rasio Kapitalisasi marang Aset Bersih Jazz Pharmaceuticals|CYTK (cytokinetics.com) - Rasio Kapitalisasi marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku PTC Therapeutics PTCT|Kapitalisasi Pasar marang Aset Bersih Scholar Rock, Inc.|Centessa Pharmaceuticals PLC (CNTA) - Rasio Kapitalisasi Pasar marang Nilai Buku|Nilai Pasar marang Nilai Buku Dyne Corp (DYN)|Rasio Kapitalisasi Pasar marang Nilai Buku EWTX (Edgewise Therapeutics)|rapportrx.com - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Alumis (ALMS)|ZVRA: Nilai Pasar marang Nilai Buku|CTNM (Contineum Pharma) - Rasio Nilai Pasar marang Nilai Buku|Larimar Corp (LRMR) - Rasio Kapitalisasi marang Aset Bersih|CAPR (Capricor Therapeutics Inc.) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku entradatx.com (TRDA)|Channel Therapeutics Corp (PTHS) - Rasio Kapitalisasi marang Aset Bersih|Nilai Pasar marang Nilai Buku MNOV (medicinova.com)|SER - Rasio Nilai Pasar marang Nilai Buku|Rasio Kapitalisasi marang Nilai Buku BioXcel Therapeutics Corp BTAI|PMN (ProMIS) - Rasio Kapitalisasi Pasar marang Nilai Buku|Apimeds Pharmaceuticals (APUS) - Koefisien Nilai Pasar marang Nilai Buku|AEON: Rasio Kapitalisasi marang Aset Bersih|NLSP (NLS Pharmaceutics) - Rasio Kapitalisasi Pasar marang Nilai Buku|HUGE - Rasio Nilai Pasar marang Nilai Buku|Nilai Pasar marang Nilai Buku RETA